Hintergrund: Die Datenlage zur ESD im Ösophagus ist außerhalb Asiens spärlich.
Insbesondere ist der Stellenwert der ESD in der Therapie der frühen Barrettneoplasie …

Zusammenfassung Die endoskopische Submukosa-Dissektion (ESD) im Ösophagus stellt
ein technisch anspruchsvolles und klinisch neues Verfahren zur „En-bloc “-Resektion von …

Background and study aims: Endoscopic submucosal dissection (ESD) carries significant
advantages over endoscopic mucosal resection. As such, ESD is an established therapy for …

Background and Aims Endoscopic submucosal dissection (ESD) is carving out an
increasing role in the treatment of esophageal neoplasia in the Western world. Contrary to …

Aims In Europe, endoscopic submucosal dissection (ESD) is not yet the standard treatment
for premalignant or early malignant lesions in the gastrointestinal (GI)-tract. High quality data …

Introduction The possible benefit of endoscopic submucosal dissection (ESD) for early
neoplasia arising in Barrett's esophagus remains controversial. We aimed to assess the …

The incidence of Barrett's esophageal cancer is one of the most rapidly increasing among all
cancers in the West, and it is also expected to increase in Japan. The optimal treatment for …

Background The use of endoscopic submucosal dissection (ESD) is gradually expanding for
treatment of neoplasia in Barrett's esophagus (BE). We aimed to report outcomes of all ESDs …

Background and aims Piecemeal endoscopic mucosal resection (EMR) is the standard
treatment of nodular Barrett's esophagus dysplasia and T1a cancer. Piecemeal resection …

The incidence of esophageal cancer has been increasing while the prognosis remains very
poor. Endoscopic submucosal dissection (ESD) was developed in Japan for en bloc …